Compounds > n-(3-(aminomethyl)benzyl)acetamidine
Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Retinal Vein Occlusion

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Retinal Vein Occlusion in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Retinal Vein Occlusion: Blockage of the RETINAL VEIN. Those at high risk for this condition include patients with HYPERTENSION; DIABETES MELLITUS; ATHEROSCLEROSIS; and other CARDIOVASCULAR DISEASES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sennlaub, F1
Courtois, Y1
Goureau, O1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Retinal Vein Occlusion

ArticleYear
Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, May-15, Volume: 22, Issue:10

    Topics: Aging; Amidines; Animals; Animals, Newborn; Apoptosis; Benzylamines; Cell Count; Crosses, Genetic; D

2002